Year: 2019
Type: review
Institutions: Broad Institute, Harvard University, Massachusetts General Hospital, Massachusetts Institute of Technology, Brigham and Women's Hospital, Thrombolysis in Myocardial Infarction Study Group, Spanish National Centre for Cardiovascular Research, Verve Therapeutics (United States), Stanford Medicine, Stanford University
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Funders: American Heart Association, Amgen, AstraZeneca, Massachusetts General Hospital, Boston Scientific Corporation, Regeneron Pharmaceuticals, Ministerio de Ciencia, Innovación y Universidades, Fondation Leducq, Centro Nacional de Investigaciones Cardiovasculares, National Institutes of Health, National Heart, Lung, and Blood Institute
Awards: G1299449749, G1595975505, G3741318032, G4169769675, G4463822314, Risk Prediction and Personalizing Therapy to Prevent Critical Limb ischemia in Patients with PAD and Diabetes, G5240891896, Understanding modifiers of mendelian mutation penetrance using familial hypercholesterolemia as a model, G5454720240, Somatic TET2 mutation-driven clonal hematopoiesis in atherosclerosis, G603018768, G6355960561, G8251085824, G8792955249, Clonal hematopoiesis and atherosclerosis, Whole genome sequences in ethnically diverse individuals to comprehensively characterize the genetic mechanisms of dyslipidemias, Training Grant in Cardiovascular Research
OpenAlex ID: W2963444387